Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
A rational approach to nutritional assessment
2008
An update on LDL apheresis for nephrotic syndrome
2018
RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age‐Related Macular Degeneration
2010
Immunoadsorption in dermatology
2010
Therapeutic plasma exchange in poisoning: 8 years' experience of a university hospital
2015
Incorporation of low-density lipoprotein apheresis into the treatment program of patients with severe hypercholesterolemia
2000
Management of acute organophosphorus pesticide poisoning
2007 Standout
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Albumin turnover: experimental approach and its application in health and renal diseases
2004
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD
1998
Immunoadsorption patients with multiple sclerosis: an open‐label pilot study
2005
Low‐density Lipoprotein Apheresis in the Treatment of Peripheral Arterial Disease
2003
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Successful removal of pathogenic autoantibodies in pemphigus by immunoadsorption with a tryptophan-linked polyvinylalcohol adsorber
2003
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Dextran‐sulfate‐adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid‐apheresis—Comparison of performance characteristics with DALI and lipidfiltration
2007
Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany
2015
A Case Report of Efficiency of Double Filtration Plasmapheresis in Treatment of Goodpasture's Syndrome
2009
Immunoadsorption of factor VIII inhibitors
2004
Low‐Density Lipoprotein Apheresis and Changes in Plasma Components
2001
The Beneficial Effects of Plasma Exchange After Severe Burn Injury
2009
Rheopheresis: Rheologic, Functional, and Structural Aspects
2000
Therapeutic pediatric apheresis
2000
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Cytapheresis in the treatment of cell-affected blood disorders and abnormalities
2006
Hydrogel: Preparation, characterization, and applications: A review
2013 Standout
Cardiac calcification in adult hemodialysis patients
2002 Standout
In face of the increasing efficacy of lipid-lowering therapy, is there still a place for LDL-apheresis?
2004
Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
2000 Standout
Medications in Patients Treated With Therapeutic Plasma Exchange: Prescription Dosage, Timing, and Drug Overdose
2012
Current applications of plasmapheresis in clinical toxicology
2003
What’s going on in LDL apheresis
2007
Efficacy of Different Low‐Density Lipoprotein Apheresis Methods
2000
Biomedical applications of biodegradable polymers
2011 Standout
From Membrane Differential Filtration to Lipidfiltration: Technological Progress in Low‐density Lipoprotein Apheresis
2003
Acute Renal Failure
1996 Standout
Lipidfiltration––safe and effective methodology to perform lipid-apheresis
2004
Expression of Human CD81 in Transgenic Mice Does Not Confer Susceptibility to Hepatitis C Virus Infection
2002 StandoutNobel
Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
2015
Low‐density Lipoprotein Apheresis: An Overview
2003
Recommendations for the use of LDL apheresis
2008
Low‐Density Lipoprotein Apheresis: Clinical Results with Different Methods
2002
Therapeutic Apheresis Rescue Mission: Recurrent Focal Segmental Glomerulosclerosis in Renal Allografts
2011
Plasma Exchange for Kidney Disease: What Is the Best Evidence?
2014
Myasthenia gravis
2019 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia
2007
Effect of different LDL‐apheresis methods on parameters involved in atherosclerosis
2004
The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels
2000
Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management
2007
Indication of Low‐density Lipoprotein Apheresis in Severe Hypercholesterolemia and its Atherosclerotic Vascular Complications: Dextran Sulfate Cellulose Low‐density Lipoprotein Apheresis
2003
Immunoadsorption method using immunoglobulin Adsopak in adult cases with ITP resistant to splenectomy and other medical therapies
2008
Current therapy of the pemphigus group
2011
Drug Removal by Plasmapheresis: An Evidence‐Based Review
2007
Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV‐related cryoglobulinemia
2009
Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: An effective protocol
2008
Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis
2017
Pathogenic roles of cardiac autoantibodies in dilated cardiomyopathy
2005 StandoutNobel
Prevention and treatment of alloantibody-mediated kidney transplant rejection
2011
Contact Activation in Low‐density Lipoprotein Apheresis Systems
2005
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Low-density lipoprotein apheresis as a treatment option for hyperlipidemia
2009
The Role of Oxidative Stress–Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
2004
Low‐density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow‐up to 21 Years
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Burn injury
2020 Standout
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
2009
Ferroptosis and Necroptosis in the Kidney
2020
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab
2008
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis
2009
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Low‐density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin‐induced thrombocytopenia and thrombosis
2010
Use of Therapeutic Plasma Exchange in the Burn Unit
2013
A Case Report of Double‐Filtration Plasmapheresis for the Treatment of Age‐related Macular Degeneration
2008
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study
1996
Optimization of therapeutic procedure during LDL-apheresis – verification of the computerized model in clinical practice
2007
Low‐density Lipoprotein Apheresis Therapy With a Direct Hemoperfusion Column: A Japanese Multicenter Clinical Trial
2006
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical results
1998
Changes in HCV Viremia following LDL Apheresis in a HCV Positive Patient with Familial Hypercholesterolemia
1999
Plasma exchange effectively removes 52‐ and 60‐kDa anti‐Ro/SSA and anti‐La/SSB antibodies in pregnant women with congenital heart block
2015
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study
2003 Standout
Biodegradable polymers as biomaterials
2007 Standout
Biocompatibility of hemodialysis membranes.
1990
III Diretrizes Brasileiras Sobre Dislipidemias e Diretriz de Prevenção da Aterosclerose do Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia
2001 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
2010 StandoutNobel
National heart, lung, and blood institute state of the science symposium in therapeutic apheresis—Therapeutic apheresis in cardiovascular disease
2014
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Current and emerging therapies for the treatment of myasthenia gravis
2011
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
1998
Medical applications of membranes: Drug delivery, artificial organs and tissue engineering
2007
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Maximizing the right stuff: The trade-off between membrane permeability and selectivity
2017 StandoutScience
Hematological Problems in Pediatric Intensive Care
2013 Standout
Therapeutic Plasma Exchange in Patients with Chylomicronemia Syndrome Complicated by Acute Pancreatitis
1999
Vascular access for red blood cell exchange
2018
Organophosphorus poisoning (acute).
2004
Works of Thomas Bosch being referenced
Lipid Apheresis by Hemoperfusion: In Vitro Efficacy and Ex Vivo Biocompatibility of a New Low‐Density Lipoprotein Adsorber Compatible with Human Whole Blood
1993
State of the Art of Low‐density Lipoprotein Apheresis in the Year 2003
2004
Efficacy and safety of DALI LDL‐apheresis at high blood flow rates: A prospective multicenter study
2003
Vascular Access for Apheresis in Intensive Care Patients
2003
Direct Adsorption of Low‐Density Lipoprotein by DALI‐LDL‐Apheresis: Results of a Prospective Long‐term Multicenter Follow‐up Covering 12 291 Sessions
2006
LDL Hemoperfusion‐A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood
1997
Recent advances in therapeutic apheresis
2003
A simultaneous study of the metabolism of apolipoprotein B and albumin in nephrotic patients
1998
Background and Indications for Protein A‐Based Extracorporeal Immunoadsorption
2001
Therapeutic Plasma Exchange in the Intensive Care Setting
2001
LDL Hemoperfusion‐A New Procedure for LDL Apheresis: Biocompatibility Results from a First Pilot Study in Hypercholesterolemic Atherosclerosis Patients
1997
Direct Adsorption of Lipoproteins from Whole Blood by DALI Apheresis: Technique and Effects
2001
Current Status in Extracorporeal Immunomodulation: Immune Disorders
1996
State of the Art of Lipid Apheresis
1996
Therapeutic Apheresis—State of the Art in the Year 2005
2005
Clinical Effects of Direct Adsorption of Lipoprotein Apheresis: Beyond Cholesterol Reduction
2003
Direct adsorption of low‐density lipoprotein and lipoprotein(a) from whole blood: Results of the first clinical long‐term multicenter study using DALI apheresis
2002
Low–Density Lipoprotein Hemoperfusion Using a Modified Polyacrylate Adsorber: In Vitro, Ex Vivo, and First Clinical Results
1996
Plasmapheresis in C4d‐positive Acute Humoral Rejection Following Kidney Transplantation: A Review of 4 Cases
2003
Improvement of Hemorheology by DALI Apheresis: Acute Effects on Plasma Viscosity and Erythrocyte Aggregation in Hypercholesterolemic Patients
2001
DALI Apheresis in Hyperlipidemic Patients: Biocompatibility, Efficacy, and Selectivity of Direct Adsorption of Lipoproteins from Whole Blood
2000
Immunoadsorption, current status and future developments
2000
Extracorporeal Plasma Treatment in Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: A Review
2001
Biocompatibility and clinical performance of a new modified cellulose membrane.
1986
Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure
1993
Ex vivo model of hemodialysis membrane biocompatibility.
1985
Extracorporeal Plasma Treatment in Primary and Recurrent Focal Segmental Glomerular Sclerosis: A Review
2001
New Aspects of Low‐density Lipoprotein Apheresis
2003
A Clinical Study on Different Cellulosic Dialysis Membranes
1987
Reverse Flux Filtration: A New Mode of Therapy Improving the Efficacy of Heparin - Induced Extracorporeal Ldl Precipitation in Hyperlipidemic Hemodialysis Patients
1993
Heparin-Free DALI LDL-Apheresis in Hyperlipidemic Patients: Efficacy, Safety and Biocompatibility
2000
Overview: Techniques and Indications of LDL-Apheresis
1991
Efficacy of Lipid Apheresis: Definitions and Influencing Factors
1995
Extracorporeal Plasma Treatment in Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome: A Review
2001